Please login to the form below

Not currently logged in
Email:
Password:

Pharma market

This page shows the latest Pharma market news and features for those working in and with pharma, biotech and healthcare.

The end of pharma

The end of pharma

Glucose monitoring companies cooperate with diabetes pharma companies. In the market for medical technology, companies like Philips, Siemens and GE Healthcare sell integrated systems that optimise health economic outcomes. ... Our market might follow

Latest news

  • Novartis makes case for NASH candidate tropifexor Novartis makes case for NASH candidate tropifexor

    NASH is commonly associated with obesity, diabetes and high-cholesterol – currently, there are no approved treatments for the condition, and the race to market has seen multiple pharma companies fail in ... A number of other major pharma companies such

  • AstraZeneca launches $1bn Chinese investment fund AstraZeneca launches $1bn Chinese investment fund

    AZ is among the top investors in the country with a strong market presence. ... As the world’s second-largest healthcare market after the US, China has been a target for many big pharma companies, and AstraZeneca is already among the multinational drug

  • German pharma experiencing a ‘Brexit boost’ German pharma experiencing a ‘Brexit boost’

    Opinion poll ranked Germany as top pharma market in EU. According to research conducted by CPhI Worldwide, Germany is experiencing a ‘Brexit boost’ in its pharma industry, and has been ranked ... In the same time that Germany's pharma market has

  • The business case for patient engagement The business case for patient engagement

    Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools. ... Once reimbursed, digital medicines may well start eating into this spending, effectively shrinking the market for pharma’s

  • NICE delivers final ‘no’ for Novartis’ migraine treatment Aimovig NICE delivers final ‘no’ for Novartis’ migraine treatment Aimovig

    Since being approved by the European Commission in  2018, Novartis has seen rivals emerge from Eli Lilly (Emgality) and Teva (Ajovy) introduced to the market. ... However, Aimovig has established itself as market lead, with Evaluate Pharma estimating

More from news
Approximately 2 fully matching, plus 408 partially matching documents found.

Latest Intelligence

  • Pharmaceutical innovation in the APAC region Pharmaceutical innovation in the APAC region

    The following fresh perspective on innovation in the APAC pharma market is excerpted from a data-driven analysis that ranked companies on their degree of innovation, using a methodology expressly developed ... Bio-pharma Manufacturers Association (KPBMA)

  • Biotech profile: Tom Evans, CEO, Vaccitech.

    Tom Evans. Pharma Market Europe talks to its chief executive Tom Evans, a veteran research and business leader in viral diseases, with experience across academia, big pharma and biotech. ... The market is very competitive but we’re doing something

  • Gene therapy market access Q&A Gene therapy market access Q&A

    Jesper Jorgensen, Health Economics and Market Access Manager, Cell and Gene Therapy Catapult. ... Could Europe steal a march on the US if it gets cell and gene market access right?

  • NHS regional footprints NHS regional footprints

    Pharma must keep abreast of the needs and priorities of each regional footprint. ... In line with this, pharma needs to understand market segmentation for its products to identify where and how they offer best value.

  • AstraZeneca’s oncology renaissance AstraZeneca’s oncology renaissance

    When Pharma Market Europe named Susan Galbraith in its list of 30 Women Leaders in UK Healthcare in June this year, Pangalos was quick to credit her role in the renaissance. ... KUDOS had discovered olaparib, the first-in- class PARP inhibitor, which

More from intelligence
Approximately 0 fully matching, plus 99 partially matching documents found.

Latest appointments

  • New faces at Prime Global, Swordfish Advertising and Wilmington Healthcare New faces at Prime Global, Swordfish Advertising and Wilmington Healthcare

    They also have additional experience of the challenges in an evolving payer environment, gained in prior roles in the NHS, the pharma industry and market access consulting. ... She has a wealth of experience in providing consultancy on market access,

  • Janssen's Matthew Kirby takes up senior role at Wilmington Healthcare Janssen's Matthew Kirby takes up senior role at Wilmington Healthcare

    Having spent many years working in the pharma industry in sales, market access and business development roles, Matthew has a wealth of knowledge and experience, and he will be a very ... Before joining Janssen Kirby was at Nycomed Pharmaceuticals, where

  • Bayer UK and Ireland appoints new CEO Bayer UK and Ireland appoints new CEO

    was head of the pharma group’s global market access business. ... He said: “Looking in from afar, the progress the UK and Ireland has made over the last four years alone, with the UK becoming the third largest Bayer market in Europe

  • Medmeme bolsters its sales team Medmeme bolsters its sales team

    Mahesh Naithani, founder of Medmeme, said: “Franco is ideally placed to drive sales for Medmeme’s unique offering which can yield transformative and market-differentiating benefits for pharma and other healthcare

  • MRN expands operations with new senior director MRN expands operations with new senior director

    He said: “In my previous role, I was becoming more and more aware and interested in the growing role home healthcare and how it revolutionising both the pharma industry and health ... outcomes. “MRN is the market leader and working with pharma

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 78 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

Using human insights to push healthcare communications forward
This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives...
RWE Blog 4: The place of real-world evidence in the market access strategy
The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in...
RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...

Infographics